Compounds > irofulven
Page last updated: 2024-09-04

irofulven and Bladder Cancer

irofulven has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bekele, R; Börcsök, J; Brunak, S; Csabai, I; Dillon, KM; Diossy, M; Frazier, ZJ; Gao, SP; Hoffman-Censits, JH; Iyer, G; Konieczkowski, DJ; Lazaro, JB; Liu, D; Lozsa, R; Mouw, KW; Pappot, H; Plimack, ER; Rodrigues, JA; Rosenberg, JE; Rusz, O; Samant, AS; Solit, DB; Spisák, S; Szallasi, Z; Sztupinszki, Z; Szüts, D; Taplin, ME; Tisza, V; Van Allen, EM; Vasani, N1

Other Studies

1 other study(ies) available for irofulven and Bladder Cancer

ArticleYear
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 04-01, Volume: 27, Issue:7

    Topics: Antineoplastic Agents; Cisplatin; DNA Repair; Humans; Sesquiterpenes; Urinary Bladder Neoplasms; Xeroderma Pigmentosum Group D Protein

2021